CrushSCI.com
62.5Average days
49Median days
1Fastest days
331Longest days
1822025 publications

Paper Review Records

All Paper Review Records

24 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

28 days

Delayed Diagnosis of Adult Haemoglobinopathies: An Exploratory Retrospective Study of Diagnostic Trajectories and a Preliminary Clinical Suspicion Framework

Authors
Sophia Delicou; Aikaterini Poulaki; Iliana Mani; Christos Savvidis; Aikaterini Xydaki; Maria Moraki; Constantina Aggeli; Ioannis Ilias; John KoskinasShow moreShow less
Affiliations
1. Thalassaemia and Sickle Cell Unit, Expertise Centre of Haemoglobinopathies and Their Complications General Hospital of Athens Hippokrateio Athens Greece; 2. Second Department of Internal Medicine, Expertise Centre of Haemoglobinopathies and Their Complications General Hospital of Athens Hippokrateio Athens Greece; 3. Endocrinology Unit, Expertise Centre of Haemoglobinopathies and Their Complications General Hospital of Athens Hippokrateio Athens Greece; 4. First Department of Cardiology, Expertise Centre of Haemoglobinopathies and Their Complications General Hospital of Athens Hippokrateio, National and Kapodistrian University of Athens Athens GreeceShow moreShow less
Source PDF DOI Publisher page
128 days

Development of Chimeric Antigen Receptor‐Modified NK Cells for the Immunotherapy of Adult T‐Cell Leukemia/Lymphoma

Authors
Yuichiro Uchida; Seigo Tateo; Masahiro Wakao; Hiroyuki Shinchi; Hayate Sawayama; Akira Fukumoto; Makoto Yoshimitsu; Yasuo SudaShow moreShow less
Affiliations
1. SUDx‐Biotec Corporation Kagoshima Japan; 2. Graduate School of Science and Engineering Kagoshima University Kagoshima Japan; 3. Department of Hematology and Rheumatology, Graduate School of Medical and Dental Sciences Kagoshima University Kagoshima JapanShow moreShow less
Source PDF DOI Publisher page
63 days

Efficacy and Safety of Bendamustine Versus Fludarabine and Cyclophosphamide as Lymphodepleting Regimens for CAR ‐T Therapy in Hematological Malignancies: A Systematic Review and Meta‐Analysis

Authors
Akihiro Miyashita; Magda Sofía Jiménez Castellanos; Thomas RodgersShow moreShow less
Affiliations
1. Department of Internal Medicine University of Hawaiʻi John A. Burns School of Medicine Honolulu Hawaii USA; 2. Facultad de Medicina C‐II “Dr. Manuel Velasco Suárez” Universidad Autónoma de Chiapas, Tuxtla Gutiérrez Chiapas Mexico; 3. Department of Hematology and Medical Oncology Hawaii Pacific Health Honolulu Hawaii USA; 4. Department of Veterans Affairs Raleigh North Carolina USA; 5. Department of Medicine University of Hawaiʻi Honolulu Hawaii USAShow moreShow less
Source PDF DOI Publisher page
26 days

Multiomic Single‐Cell Sequencing Identifies BCR::ABL1 as an Acquired Resistance Mechanism in FLT3+ AML

Authors
Vanessa E. Kennedy; Cheryl A. C. Peretz; Andrew Koh; Elaine Tran; Dalia Dhingra; Saurabh Gulati; Adam Sciambi; Olga Sala‐Torra; Lan Beppu; Jerald P. Radich; Catherine C. SmithShow moreShow less
Affiliations
1. Department of Medicine Stanford University Stanford California USA; 2. Division of Oncology, Department of Pediatrics University of California San Francisco San Francisco California USA; 3. Division of Hematology/Oncology, Department of Medicine University of California San Francisco San Francisco California USA; 4. Mission Bio San Francisco California USA; 5. Fred Hutchinson Cancer Center Seattle Washington USAShow moreShow less
Source PDF DOI Publisher page
50 days

Evaluation of the Eosin‐5′‐Maleimide Flow Cytometry Test for the Diagnosis of Hereditary Spherocytosis

Authors
Pablo Adrian Biaggioni; Alejandro Ceferino López RomeroShow moreShow less
Affiliations
1. Hematology Department and Teaching Department IACA Laboratorios Bahía Blanca Argentina; 2. Hematology Department IACA Laboratorios Bahía Blanca ArgentinaShow moreShow less
Source PDF DOI Publisher page
15 days

Minimal Residual Disease as a Biological Trait: Rethinking Disease Persistence in Hematologic Malignancies

Authors
Santino Caserta; Enrica Antonia Martino; Ernesto Vigna; Mamdouh Skafi; Antonella Bruzzese; Nicola Amodio; Eugenio Lucia; Graziella D'Arrigo; Virginia Olivito; Caterina Labanca; Francesco Mendicino; Maria Eugenia Alvaro; Giovanni Tripepi; Fortunato Morabito; Massimo GentileShow moreShow less
Affiliations
1. Hematology Unit, Department of Onco‐Hematology, AO of Cosenza Cosenza Italy; 2. Emergency and Internal Medicine Department Saint Joseph Hospital East Jerusalem Palestine; 3. Department of Experimental and Clinical Medicine University of Catanzaro Catanzaro Italy; 4. Istituto di Fisiologia Clinica del CNR di Reggio Calabria, Consiglio Nazionale Delle Ricerche Reggio Calabria Italy; 5. AIL Sezione di Cosenza Cosenza Italy; 6. Department of Pharmacy, Health and Nutritional Science University of Calabria Rende ItalyShow moreShow less
Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review62 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at [email protected]

Enter your email address so we can reply. Your details will remain private.